217 related articles for article (PubMed ID: 11117248)
21. A randomized controlled trial comparing mupirocin versus Polysporin Triple for the prevention of catheter-related infections in peritoneal dialysis patients (the MP3 study).
Jassal SV; Lok CE;
Perit Dial Int; 2008; 28(1):67-72. PubMed ID: 18178950
[TBL] [Abstract][Full Text] [Related]
22. Mupirocin application at the exit site in peritoneal dialysis patients: five years of experience.
Aykut S; Caner C; Ozkan G; Ali C; Tugba A; Zeynep G; Taner C
Ren Fail; 2010 Jan; 32(3):356-61. PubMed ID: 20370452
[TBL] [Abstract][Full Text] [Related]
23. A prospective study of the efficacy of local application of gentamicin versus mupirocin in the prevention of peritoneal dialysis catheter-related infections.
Chu KH; Choy WY; Cheung CC; Fung KS; Tang HL; Lee W; Cheuk A; Yim KF; Chan WH; Tong KL
Perit Dial Int; 2008; 28(5):505-8. PubMed ID: 18708544
[TBL] [Abstract][Full Text] [Related]
24. Mupirocin once weekly reduces the incidence of catheter exit-site infection in peritoneal dialysis patients.
Al-Hilali NA; Ninan VT; Al-Humoud HA; Nampoory MR; Johny KV
Perit Dial Int; 2005; 25(1):91-2. PubMed ID: 15770932
[No Abstract] [Full Text] [Related]
25. The impact of topical mupirocin on peritoneal dialysis infection in Singapore General Hospital.
Lim CT; Wong KS; Foo MW
Nephrol Dial Transplant; 2005 Oct; 20(10):2202-6. PubMed ID: 16046516
[TBL] [Abstract][Full Text] [Related]
26. Effect of once-a-week vs thrice-a-week application of mupirocin on methicillin and mupirocin resistance in peritoneal dialysis patients: three years of experience.
Cavdar C; Saglam F; Sifil A; Celik A; Atay T; Gungor O; Ozder A; Gulay Z; Camsari T
Ren Fail; 2008; 30(4):417-22. PubMed ID: 18569916
[TBL] [Abstract][Full Text] [Related]
27. Prophylaxis against gram-positive organisms causing exit-site infection and peritonitis in continuous ambulatory peritoneal dialysis patients by applying mupirocin ointment at the catheter exit site.
Wong SS; Chu KH; Cheuk A; Tsang WK; Fung SK; Chan HW; Tong MK
Perit Dial Int; 2003 Dec; 23 Suppl 2():S153-8. PubMed ID: 17986538
[TBL] [Abstract][Full Text] [Related]
28. An analysis of methods to prevent peritoneal dialysis catheter infections.
Piraino B; Bernardini J; Bender FH
Perit Dial Int; 2008; 28(5):437-43. PubMed ID: 18708532
[No Abstract] [Full Text] [Related]
29. Regional variation in the treatment and prevention of peritoneal dialysis-related infections in the Peritoneal Dialysis Outcomes and Practice Patterns Study.
Boudville N; Johnson DW; Zhao J; Bieber BA; Pisoni RL; Piraino B; Bernardini J; Nessim SJ; Ito Y; Woodrow G; Brown F; Collins J; Kanjanabuch T; Szeto CC; Perl J
Nephrol Dial Transplant; 2019 Dec; 34(12):2118-2126. PubMed ID: 30053214
[TBL] [Abstract][Full Text] [Related]
30. Topical mupirocin/sodium hypochlorite reduces peritonitis and exit-site infection rates in children.
Chua AN; Goldstein SL; Bell D; Brewer ED
Clin J Am Soc Nephrol; 2009 Dec; 4(12):1939-43. PubMed ID: 19820132
[TBL] [Abstract][Full Text] [Related]
31. Spontaneous peritoneal catheter extrusion.
Nowicki M; Jander A; Czupryniak A; Kaluzynska A
Perit Dial Int; 2002; 22(2):277-8. PubMed ID: 11990420
[No Abstract] [Full Text] [Related]
32. Comparison of topical mupirocin and gentamicin in the prevention of peritoneal dialysis-related infections: A systematic review and meta-analysis.
Tsai CC; Yang PS; Liu CL; Wu CJ; Hsu YC; Cheng SP
Am J Surg; 2018 Jan; 215(1):179-185. PubMed ID: 28341139
[TBL] [Abstract][Full Text] [Related]
33. Chlorhexidine for routine PD catheter exit-site care.
Olga B; Fotis Z; Margarita I; Sofia X; Konstantinos S
Int Urol Nephrol; 2016 Sep; 48(9):1543-6. PubMed ID: 27432412
[TBL] [Abstract][Full Text] [Related]
34. A randomized trial of Staphylococcus aureus prophylaxis in peritoneal dialysis patients: mupirocin calcium ointment 2% applied to the exit site versus cyclic oral rifampin.
Bernardini J; Piraino B; Holley J; Johnston JR; Lutes R
Am J Kidney Dis; 1996 May; 27(5):695-700. PubMed ID: 8629630
[TBL] [Abstract][Full Text] [Related]
35. The effect on peritoneal dialysis pathogens of changing topical antibiotic prophylaxis.
Pierce DA; Williamson JC; Mauck VS; Russell GB; Palavecino E; Burkart JM
Perit Dial Int; 2012; 32(5):525-30. PubMed ID: 22302770
[TBL] [Abstract][Full Text] [Related]
36. Antimicrobial agents for preventing peritonitis in peritoneal dialysis patients.
Campbell D; Mudge DW; Craig JC; Johnson DW; Tong A; Strippoli GF
Cochrane Database Syst Rev; 2017 Apr; 4(4):CD004679. PubMed ID: 28390069
[TBL] [Abstract][Full Text] [Related]
37. Peritoneal dialysis infections recommendations.
Piraino B
Contrib Nephrol; 2006; 150():181-186. PubMed ID: 16721009
[TBL] [Abstract][Full Text] [Related]
38. Mupirocin for preventing exit-site infection and peritonitis in patients undergoing peritoneal dialysis.
Xu G; Tu W; Xu C
Nephrol Dial Transplant; 2010 Feb; 25(2):587-92. PubMed ID: 19679557
[TBL] [Abstract][Full Text] [Related]
39. Prevention of gram-positive infections in peritoneal dialysis patients in Hong Kong: a cost-effectiveness analysis.
Wong C; Luk IW; Ip M; You JH
Am J Infect Control; 2014 Apr; 42(4):412-6. PubMed ID: 24679568
[TBL] [Abstract][Full Text] [Related]
40. Effect of preventing Staphylococcus aureus carriage on rates of peritoneal catheter-related staphylococcal infections. Literature synthesis.
Ritzau J; Hoffman RM; Tzamaloukas AH
Perit Dial Int; 2001; 21(5):471-9. PubMed ID: 11757831
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
